Jatter,
I'll still back myself. You lot said the same about the investment experts and analysts and the ex-sirtex management! And who was right?
So I'll stick to my guns and point out to you that the CE marking process is dead... and the IDE was rejected. Rather than rejoicing about another dead wood appointment, why not ask Daniel to release the FDA response to the IDE application?
End of February now? pffft not a hope in hell! Can they get approval ever? OSL hasn't even done the basic groundwork to even start a clinical trial!
Regards,
Jatter, I'll still back myself. You lot said the same about the...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $27.18M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $10.56K | 1.284M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7559291 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 5463874 | 5 |
View Market Depth
| Last trade - 12.19pm 25/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |